
Nationwide Epilepsy Clinical Trial Investigates Potential New Treatment
By Brandpoint (BPT) (BPT) – There is a new study evaluating a promising potential new treatment for epilepsy called Rise. Clinics across the nation are currently seeking to enroll participants in this study between the ages of 18-75 who have been diagnosed with focal (partial) onset epilepsy and have experienced resistance to existing treatments. Epilepsy
Continue Reading